周剂量奈达铂同步后程加速超分割放疗联合体外高频热疗对局部晚期食管癌患者疗效及生存率影响.doc

周剂量奈达铂同步后程加速超分割放疗联合体外高频热疗对局部晚期食管癌患者疗效及生存率影响.doc

  1. 1、本文档共13页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
周剂量奈达铂同步后程加速超分割放疗联合体外高频热疗对局部晚期食管癌患者疗效及生存率影响

周剂量奈达铂同步后程加速超分割放疗联合体外高频热疗对局部晚期食管癌患者疗效及生存率影响   [摘要] 目的 探?周剂量奈达铂同步后程加速超分割放疗联合体外高频热疗对局部晚期食管癌患者疗效及生存率的影响。 方法 选取2010年6月~2012年9月河北省承德市肿瘤医院收治的60例晚期食管癌患者作为研究对象,采用随机数字表法将其分为观察组(30例)和对照组(30例),对照组采用周剂量奈达铂同步后程加速超分割放疗治疗,观察组采用周剂量奈达铂同步后程加速超分割放疗联合体外高频热疗治疗,比较两组患者临床疗效、生存率、生命质量,以及不良反应发生情况。 结果 观察组有效率为86.6%(26/30),明显高于对照组的63.3%(19/30),差异有统计学意义(P 0.05);观察组患者中位生存时间为21个月,对照组为18个月;两组组内治疗前后社会功能、情绪功能、躯体功能、总体症状评分比较差异有统计学意义(P 0.05)。 结论 周剂量奈达铂同步后程加速超分割放疗联合体外高频热疗治疗局部晚期食管癌有助于提高患者生活质量,且未增加不良反应发生,疗效显著,值得在临床上推广应用 [关键词] 食管癌;同步后程加速超分割放疗;体外高频热疗;奈达铂;生存率 [中图分类号] R735.1 [文献标识码] A [文章编号] 1673-7210(2017)04(b)-0087-04 [Abstract] Objective To investigate the influence late course accelerated fractionated irradiation with weekly Nedaplatin combined with extracorporeal high-frequency hyperthermia on the effect and survival rate of patients with locally advanced esophageal cancer. Methods Sixty patients with locally advanced esophageal cancer admitted to Chengde Tumour Hospital from June 2010 to September 2012 were selected as the research objects, they were divided into the observation group (30 cases) and the control group (30 cases) by random number table. The control group was treated by late course accelerated fractionated irradiation with weekly Nedaplatin, the observation group was treated by late course accelerated fractionated irradiation with weekly Nedaplatin combined with extracorporeal high-frequency hyperthermia. The clinical efficacy, survival rate, quality of life and the conditions of adverse reactions between the two groups were compared. Results The effective rate of the observation group was 86.6% (26/30), which was significantly higher than the control group [63.3% (19/30)], the difference was statistically significant (P 0.05); the median survival time of the observation group was 21 months, which of control group was 18 months; the scores of social function, emotional function, physical function, overall symptom score within the two groups before and after treatment had significa

文档评论(0)

docman126 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档